Neurology News and Research

Latest Neurology News and Research

People with MS have much greater risk of dying younger compared to people without MS

New research suggests people with multiple sclerosis (MS) may have double the risk of dying early compared to people without MS, with those younger than 59 at a three times higher risk. The study is published in the May 27, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

28 May 2015

Researchers identify chemical pathway associated with seizures, shorter survival in patients with malignant glioma

Researchers at the University of Alabama at Birmingham have identified a chemical pathway that may be associated with seizures and shorter patient survival in some patients with malignant glioma, the most common and deadly form of brain tumor. In findings published May 27 in Science Translational Medicine, the researchers suggest that a transporter known as SXC is responsible for boosting levels of glutamate in the brains of some glioma patients.

28 May 2015

St. Luke’s, Greater Delaware Valley Chapter of MS Society partner to improve MS care

St. Luke’s Neurology Associates and the Greater Delaware Valley Chapter of the National Multiple Sclerosis Society agreed to a “Partners in MS Care” partnership.

28 May 2015

Salix Pharmaceuticals receives FDA approval for Xifaxan 550 mg to treat IBS-D in adults

Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Salix Pharmaceuticals, Inc., has received approval from the U.S. Food and Drug Administration for Xifaxan 550 mg for the treatment of IBS-D in adults.

28 May 2015

Carbon monoxide may actually protect the brain from damage after subarachnoid hemorrhage

Carbon monoxide is known by many as a poisonous gas that causes brain injury and other neurological symptoms, including memory loss and confusion. But a new study led by investigators at Beth Israel Deaconess Medical Center suggests the opposite may be true: When administered in small, carefully controlled amounts, carbon monoxide may actually protect the brain from damage following subarachnoid hemorrhage, a devastating stroke that results from bleeding in the brain.

27 May 2015

Scientists identify molecular 'lock' that enables Ebola virus to gain entry to cells

An international team including scientists from Albert Einstein College of Medicine of Yeshiva University and the U.S. Army Medical Research Institute of Infectious Diseases has identified the molecular "lock" that the deadly Ebola virus must pick to gain entry to cells.

27 May 2015

ProMedica, UT partner to build one of nation’s top academic medical centers in northwest Ohio

In just 10 years, this nation could have a shortage of between 46,000 and 90,000 physicians. This is according to a recent report released by the Association of American Medical Colleges. Major contributing factors include a growing and aging population, plus one-third of practicing physicians with plans to retire in the next decade. These shortages are expected to be particularly challenging for communities the size of Toledo competing with larger metropolitan areas to attract future doctors and caregivers.

27 May 2015

UF research opens door to better diagnosis and treatment of Parkinson's disease

University of Florida researchers have identified a biomarker that shows the progression of Parkinson's disease in the brain, opening the door to better diagnosis and treatment of the degenerative disease.

27 May 2015

Just think about it: Giving natural movement to a patient with quadriplegia

Paralysis is often the result of nerve damage that prevents commands from the brain being relayed to muscle to cause movement...

22 May 2015

TGen and Baylor partnership set to increase treatment options for cancer patients

The Translational Genomics Research Institute (TGen) and Baylor Research Institute (BRI) at Dallas today announce an agreement that will focus on accelerating early detection and treatments for patients with a broad range of cancers.

22 May 2015

Magstim Announces FDA (510k) Clearance of rTMS (repetitive Transcranial Magnetic Stimulation) Therapy System

Magstim is the pioneer of TMS technology, having built a reputation for developing leading medical devices in the research field for over 25 years. ..

From Magstim 21 May 2015

Depression may be a risk factor for Parkinson's disease, say Umeå University researchers

People with depression may be more likely to develop Parkinson's disease, according to a large study by researchers at Umeå University, Sweden, published on 20 May, 2015, in the online issue of Neurology, the medical journal of the American Academy of Neurology.

21 May 2015

Researchers find that blocking MCAM molecule could slow progression of multiple sclerosis

A drug that could halt the progression of multiple sclerosis may soon be developed thanks to a discovery by a team at the CHUM Research Centre and the University of Montreal. The researchers have identified a molecule called MCAM, and they have shown that blocking this molecule could delay the onset of the disease and significantly slow its progression.

21 May 2015

Magstim Rapid2 Therapy System receives FDA clearance for treatment of drug resistant MDD

The Magstim Company Ltd, an innovative and award winning Wales-based medical device manufacturer, has received FDA 510(k) clearance to market its Magstim Rapid2 Therapy System for the treatment of drug resistant Major Depressive Disorder (MDD) in the United States. The clearance enables Magstim to significantly increase access to cutting-edge Repetitive Transcranial Magnetic Stimulation (rTMS) technology for patients and clinicians.

From Magstim 20 May 2015

DNAtrix signs agreement to utilize Alcyone's MEMS platform for direct drug delivery into glioblastoma

Alcyone Lifesciences, Inc., a leader in neural intervention systems for neurological conditions and targeted drug delivery, and DNAtrix Inc., a privately held biotechnology company and a leader in oncolytic virus therapy, have entered into an exclusive clinical collaboration. Under the agreement, DNAtrix will utilize Alcyone's MEMS Cannula (AMC) targeted delivery platform for the intratumoral delivery of DNX-2401, an oncolytic adenovirus and DNAtrix's lead product for the treatment of the most aggressive form of brain cancer, glioblastoma (GBM).

19 May 2015

Grass plants can bind, uptake and transport infectious prions

Grass plants can bind, uptake and transport infectious prions, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).

18 May 2015

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB, a global biopharmaceutical company focusing on immunology and neurology treatment and research, is sponsoring several data presentations on Cimzia (certolizumab pegol) at Digestive Disease Week 2015, taking place in Washington, DC from May 16-19.

17 May 2015

Neurology News and Research

Latest Neurology News and Research

People with MS have much greater risk of dying younger compared to people without MS

Researchers identify chemical pathway associated with seizures, shorter survival in patients with malignant glioma

St. Luke’s, Greater Delaware Valley Chapter of MS Society partner to improve MS care

Salix Pharmaceuticals receives FDA approval for Xifaxan 550 mg to treat IBS-D in adults

Carbon monoxide may actually protect the brain from damage after subarachnoid hemorrhage

Scientists identify molecular 'lock' that enables Ebola virus to gain entry to cells

ProMedica, UT partner to build one of nation’s top academic medical centers in northwest Ohio

UF research opens door to better diagnosis and treatment of Parkinson's disease

Just think about it: Giving natural movement to a patient with quadriplegia

TGen and Baylor partnership set to increase treatment options for cancer patients

Magstim Announces FDA (510k) Clearance of rTMS (repetitive Transcranial Magnetic Stimulation) Therapy System

Depression may be a risk factor for Parkinson's disease, say Umeå University researchers

Researchers find that blocking MCAM molecule could slow progression of multiple sclerosis

Magstim Rapid2 Therapy System receives FDA clearance for treatment of drug resistant MDD

DNAtrix signs agreement to utilize Alcyone's MEMS platform for direct drug delivery into glioblastoma

Grass plants can bind, uptake and transport infectious prions

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

APS announces recipients of prestigious achievement awards during annual scientific meeting

Denali launched to discover, develop effective medicines for neurodegenerative diseases

BrainStorm Cell Therapeutics reports financial results for Q1 2015, provides business update

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Neurology News and Research

Latest Neurology News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in